Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Business Wire India AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRCommittee for Medicinal Products for Human Use (CHMP) recommends approval of Kapruvia®(difelikefalin) as first therapy in Europe for the treatment…